Over dinner, Samira Shamoon's slim, chic friend let her in on a little secret. She was dabbling with the latest craze backed ...

Federal health officials are cracking down on telehealth companies' promotion of unapproved versions of prescription drugs, ...

In letters to Eli Lilly and Novo Nordisk, the FDA accused the companies of downplaying the risks of their GLP-1 weight loss ...

The weight-loss drug boom has, in many ways, turned into a generational market story. For perspective, the U.S. obesity ...

Southmoreland School District is in a legal battle with its teachers union over insurance coverage for prescription ...

Reinsurance company Swiss Re said on Wednesday that widespread use of GLP-1 drugs to treat obesity could reduce the annual ...

Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg ...

The FDA on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers ...